sitagliptin intermediate 2

Sitagliptin Intermediate 2 is a useful organic compound that has been used in life science related research.

cholesterol-absorption inhibitor Intermediate 2 is a potent and orally active cholesterol absorption inhibitor that reduces blood cholesterol levels.

Dacomitinib Intermediate 2 (N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine) has anticancer activity and can be used to study lung cancer.

CRAC intermediate 2 is used as an intermediate compound in the synthesis of CRAC inhibitors.

Exatecan Intermediate 2 (compound B) is a precursor used in the synthesis of Exatecan (DX-8951), an anticancer agent classified among the camptothecin analogs. Exatecan operates by interacting with DNA to disrupt the proliferation and division of tumor cells, effectively inhibiting tumor growth. It is primarily employed in research targeting various cancers, including ovarian, lung, and breast cancer.

Exatecan Intermediate 2 hydrochloride (compound B) serves as an intermediary in the synthesis of Exatecan (DX-8951), a camptothecin analog and anticancer agent. This compound operates by interacting with DNA to disrupt the proliferation and division of tumor cells, thereby inhibiting tumor growth. It is primarily researched for its potential applications in treating various cancers including ovarian, lung, and breast cancer.

MMAFintermediate 2 serves as a precursor in the synthesis of MMAF (Monomethylauristatin F). MMAF is a potent inhibitor of tubulin polymerization and a cytotoxic component of classical antibody-drug conjugates (ADCs), including Vorsetuzumab mafodotin and SGN-CD19A, serving as the ADC Cytotoxin.

SC209 intermediate-2 (Compound A9), functioning as an ADC Linker [1], serves as an intermediate for the ADC cytotoxin SC209.